FTC greenlights $53B Chevron-Hess deal - Breaking The News
Download our appPlay StoreApp Store

FTC greenlights $53B Chevron-Hess deal

EPA-EFE/ADAM DAVIS

Hess Corporation unveiled in a press release on Monday that the United States Federal Trade Commission (FTC) approved the company's acquisition agreement with Chevron Corp., worth $53 billion.

"We are very pleased that our merger with Chevron has cleared this significant regulatory hurdle," Hess CEO John Hess remarked. So as to address the agency's concerns, the two companies made a deal to keep Hess' CEO out of Chevron's Board of Directors. In a previous complaint, the FTC noted that the Hess chief "communicated with OPEC [Organization of Petroleum Exporting Countries] representatives," encouraging higher oil prices. For this reason, the US agency underlined that he must be disqualified from the Board.

Hess shared that its CEO will still serve as a Chevron representative on government relations and social investments in Guyana as well as on support for the Salk Institute’s Harnessing Plants Initiative.

Related Stocks
Hess
Chevron
Related News
Fired Dem FTC members sue Trump
Two Democratic Federal Trade Commission (FTC) members sued US President Donald Trump on Thursday over their firings, contesting the legality of their dismissals.Rebecca Kelly Slaughter and Alvaro Bedoya's legal action demands reinstatement and compensation, citing the Supreme Court's nine-decade-old ruling that safeguards independent agency officials from arbitrary removal. The dismissal notices indicated that the commissioners' ongoing roles at the...
Repsol UK to form new unit with NEO Energy
Spanish petrochemical company Repsol S.A. announced on Thursday that its British business will combine with NEO Energy Group's North Sea arm to form Neo Next Energy. The resulting unit will be managed by a joint team, with NEO owning 55% and Repsol 45%."This combination will create a jointly governed business which will call upon the key strengths of both shareholders," Repsol Exploration and Production Executive Managing Director Francisco Gea said....
Merck to buy Hengrui Pharma's drug for up to $1.8B
Merck & Co. Inc. said on Tuesday that it entered into an exclusive license agreement with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for a cardiovascular disease drug HRS-5346, currently in a phase 2 trial in China. Merck will pay $200 million upfront and commit to milestone payments of up to $1.8 billion, as well as royalties on net sales.The drug is an investigational oral small molecule inhibitor of lipoprotein(a) formation (lp(a)). "Elevated blood concentrations of...
Apollo takes 25% stake in BP Pipelines for $1B
BP plc announced on Friday that Apollo Funds will buy a non-controlling 25% stake in its pipelines business for around $1 billion. The transaction is expected to close in the second quarter of 2025. BP Pipelines owns a 12% interest in the Trans-Anatolian gas pipeline (TANAP), which carries natural gas from Azerbaijan across Turkey.BP said the funds will go toward its plan for $20 billion in divestment and other proceeds. "This [deal] unlocks capital from our...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.